219 related articles for article (PubMed ID: 29070048)
1. A framework for the design, conduct and interpretation of randomised controlled trials in the presence of treatment changes.
Dodd S; White IR; Williamson P
Trials; 2017 Oct; 18(1):498. PubMed ID: 29070048
[TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
3. Nonadherence to treatment protocol in published randomised controlled trials: a review.
Dodd S; White IR; Williamson P
Trials; 2012 Jun; 13():84. PubMed ID: 22709676
[TBL] [Abstract][Full Text] [Related]
4. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
5. Adjustment for treatment changes in epilepsy trials: A comparison of causal methods for time-to-event outcomes.
Dodd S; Williamson P; White IR
Stat Methods Med Res; 2019 Mar; 28(3):717-733. PubMed ID: 29117780
[TBL] [Abstract][Full Text] [Related]
6. The use of randomisation-based efficacy estimators in non-inferiority trials.
Gillespie D; Farewell D; Barrett-Lee P; Casbard A; Hawthorne AB; Hurt C; Murray N; Probert C; Stenson R; Hood K
Trials; 2017 Mar; 18(1):117. PubMed ID: 28274254
[TBL] [Abstract][Full Text] [Related]
7. Good intentions and ICH-GCP: Trial conduct training needs to go beyond the ICH-GCP document and include the intention-to-treat principle.
Browne LH; Graham PH
Clin Trials; 2014 Dec; 11(6):629-34. PubMed ID: 25023199
[TBL] [Abstract][Full Text] [Related]
8. Overview of the epidemiology methods and applications: strengths and limitations of observational study designs.
Colditz GA
Crit Rev Food Sci Nutr; 2010; 50 Suppl 1(s1):10-2. PubMed ID: 21132580
[TBL] [Abstract][Full Text] [Related]
9. Specifying the target difference in the primary outcome for a randomised controlled trial: guidance for researchers.
Cook JA; Hislop J; Altman DG; Fayers P; Briggs AH; Ramsay CR; Norrie JD; Harvey IM; Buckley B; Fergusson D; Ford I; Vale LD;
Trials; 2015 Jan; 16():12. PubMed ID: 25928502
[TBL] [Abstract][Full Text] [Related]
10. Five questions to consider before conducting a stepped wedge trial.
Hargreaves JR; Copas AJ; Beard E; Osrin D; Lewis JJ; Davey C; Thompson JA; Baio G; Fielding KL; Prost A
Trials; 2015 Aug; 16():350. PubMed ID: 26279013
[TBL] [Abstract][Full Text] [Related]
11. Investigating causal mechanisms in randomised controlled trials.
Lee H; Herbert RD; Lamb SE; Moseley AM; McAuley JH
Trials; 2019 Aug; 20(1):524. PubMed ID: 31443729
[TBL] [Abstract][Full Text] [Related]
12. A four-step strategy for handling missing outcome data in randomised trials affected by a pandemic.
Cro S; Morris TP; Kahan BC; Cornelius VR; Carpenter JR
BMC Med Res Methodol; 2020 Aug; 20(1):208. PubMed ID: 32787782
[TBL] [Abstract][Full Text] [Related]
13. Pre-referral rectal artesunate in severe malaria: flawed trial.
Hirji KF; Premji ZG
Trials; 2011 Aug; 12():188. PubMed ID: 21824389
[TBL] [Abstract][Full Text] [Related]
14. Introducing the new CONSORT extension for stepped-wedge cluster randomised trials.
Hemming K; Taljaard M; Grimshaw J
Trials; 2019 Jan; 20(1):68. PubMed ID: 30658677
[TBL] [Abstract][Full Text] [Related]
15. Disentangling estimands and the intention-to-treat principle.
Leuchs AK; Brandt A; Zinserling J; Benda N
Pharm Stat; 2017 Jan; 16(1):12-19. PubMed ID: 27910217
[TBL] [Abstract][Full Text] [Related]
16. Multiple imputation for patient reported outcome measures in randomised controlled trials: advantages and disadvantages of imputing at the item, subscale or composite score level.
Rombach I; Gray AM; Jenkinson C; Murray DW; Rivero-Arias O
BMC Med Res Methodol; 2018 Aug; 18(1):87. PubMed ID: 30153796
[TBL] [Abstract][Full Text] [Related]
17. The citation of relevant systematic reviews and randomised trials in published reports of trial protocols.
Pandis N; Fleming PS; Koletsi D; Hopewell S
Trials; 2016 Dec; 17(1):581. PubMed ID: 27927219
[TBL] [Abstract][Full Text] [Related]
18. Protocol adherence rates in superiority and noninferiority randomized clinical trials published in high impact medical journals.
Bamat NA; Ekhaguere OA; Zhang L; Flannery DD; Handley SC; Herrick HM; Ellenberg SS
Clin Trials; 2020 Oct; 17(5):552-559. PubMed ID: 32666826
[TBL] [Abstract][Full Text] [Related]
19. Review of randomized controlled trials: issues to consider when designing a trial.
Pandis N
Am J Orthod Dentofacial Orthop; 2013 Jun; 143(6):905-7. PubMed ID: 23726342
[No Abstract] [Full Text] [Related]
20. Per-Protocol analyses produced larger treatment effect sizes than intention to treat: a meta-epidemiological study.
Mostazir M; Taylor G; Henley WE; Watkins ER; Taylor RS
J Clin Epidemiol; 2021 Oct; 138():12-21. PubMed ID: 34161805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
